Xingcheng Wu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University · ORCID：0000-0001-5075-8969

发表论文 41 篇 · 总被引 446 次 · h-index 12

代表论文

• Long non‐coding RNA ADAMTS9‐AS1 inhibits the progression of prostate cancer by modulating the miR‐142‐5p/CCND1 axis (2021 · The Journal of Gene Medicine · 被引 19)
• Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicity (2022 · Journal of Translational Medicine · 被引 17)
• Development of a nomogram combining multiparametric magnetic resonance imaging and PSA‐related parameters to enhance the detection of clinically significant cancer across different region (2022 · The Prostate · 被引 17)
• TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway (2025 · Drug Resistance Updates · 被引 16)
• Clinical Characteristics of Adrenal Hemangioma (2024 · Journal of the Endocrine Society · 被引 14)
• A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma (2021 · Disease Markers · 被引 9)